Zhenming Fu

8PUBLICATIONS
52CO-AUTHORS
Molecular targetsCancer geneticsDisease surveillanceClinical neuropsychologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 24, 2026
Izalontamab Brengitecan (Iza-Bren), a First-in-Class EGFR-HER3 Bispecific Antibody-Drug Conjugate in Extensive-Stage Small Cell Lung Cancer: Results From a Phase Ib Study.

|Aug 16, 2022
Pan-Cancer Analysis of Microbiome Quantitative Trait Loci.

Can Chen, Yimin Cai, Yizhuo Liu

|Jan 24, 2022
Declining disease burden of HCC in the United States, 1992-2017: A population-based analysis.

Jianglong Han, Bin Wang, Wenmin Liu

|Dec 04, 2021
Development and validation of a Modified Patient-Generated Subjective Global Assessment as a nutritional assessment tool in cancer patients.

Zhenming Fu, Rui Zhang, Kun-Hua Wang

|Nov 29, 2020
The stage-specific roles of radiotherapy and chemotherapy in nodular lymphocyte predominant Hodgkin lymphoma patients: a propensity score-matched analysis of the SEER database.

Shijie Wang, Mingfang Jia, Jianglong Han

|Aug 25, 2020
Radiotherapy for patients with stage IV classical Hodgkin lymphoma: a propensity-matched analysis of the surveillance, epidemiology, and end results database.

Shijie Wang, Mingfang Jia, Jianglong Han

Pageof 2

Frequent Collaborators

2 joint publications

Shijie Wang

1 joint publications

Rui Zhang

1 joint publications

Chunhua Song

1 joint publications

Wen Hu